Navigation Links
Altaire Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under several brands
Date:9/6/2013

ate  09/2013, labeled for CVS;
  • Lot # 12042, expiration date 01/2014, labeled for Wal-Mart and CVS; 
  • Lot # 12103, expiration date 02/2015, labeled for Wal-Mart;
  • Lot # 12203, expiration date 05/2015, labeled for Wal-Mart and CVS; 
  • Lot # 12207, expiration date 05/2015, labeled for Wal-Mart;
  • Lot # 12293, expiration date 08/2015, labeled for Wal-Mart; 
  • Lot # 12352, expiration date 09/2015, labeled for Target and CVS;
  • Lot # 12356, expiration date 09/2015, labeled for Target and CVS. 
  • Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution is a non-prescription (OTC) drug product used to relieve dryness of the eye and packaged in a plastic bottle inside a unit box.  Lot numbers can be found printed horizontally on the side of the label and on the bottom flap of the box.   The lots listed above were distributed between February 2012 and April 2013.   The product was sold nationwide at retail stores.

    Altaire Pharmaceuticals is initiating the recall as a precautionary measure.  Altaire takes its mission of consumer care and providing quality products very seriously.  The company has reformulated the product with an enhanced preservative system.  All lots of the product in the 30 mL size identified with lot numbers beginning with 13 (i.e. 13000) have been made with the enhanced preservative system. 

    Altaire Pharmaceuticals is notifying its customers of the recall by phone and letters for further notification to their retail stores.  Consumers who have the product with any of the lot numbers listed above should stop use of the product immediately and return it to the place of purchase.  

    Consumers with questions regarding this recall can contact Altaire Pharmaceuticals at 1-800-258-2471, Monday – Friday from 9 am – 5 pm ET.  Consumers should contact their physician or healt
    '/>"/>

    SOURCE Altaire Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
    2. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
    4. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
    5. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
    6. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
    7. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
    8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
    9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
    10. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
    11. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... ENCINO, Calif. , June 1, 2015  Research ... to scientific, technical and medical (STM) information for life ... has been invited to present at the LD Micro ... Luxe Hotel in Los Angeles ... scheduled to present on Wednesday, June 3rd at 9:30 ...
    (Date:6/1/2015)... 1, 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... known as ,nal-IRI, in a Phase 1 investigator-sponsored study ... glioma. Data were presented at the 2015 American Society ... Chicago, IL. Results from this study show ... high-grade glioma when given intravenously.  Based in ...
    (Date:6/1/2015)... , June 1, 2015 ... weight over large area and improve the quality life ... ulcer. These devices play a significant role in inhibiting ... reduce the need to turn or rotate an immobile ... include mattress, mattresses overlay, and specialty beds. These devices ...
    Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3
    ... Inc. (NYSE: WST ) today announced that Donald E. ... Federici, Chief Financial Officer, will attend the Lazard Capital Markets ... present an overview of West,s business and outlook on Tuesday, ... of the corporate presentation document as well as a live ...
    ... Ill., Nov. 12 Nearly one in three adult Americans ... 34 million have low HDL "good" cholesterol levels. To ... Abbott has launched two Web sites: www.knowyourhdl.com ... triglyceride and low HDL levels are factors that can raise ...
    Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2
    (Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in business. NAPW is the ... more than 700,000 members and over 200 operating Local ... important honor,” said NAPW President Star Jones. “Her perseverance, ...
    (Date:6/1/2015)... (PRWEB) June 01, 2015 Carson Energy ... facilitate their investors IRA transactions. AdvantaIRA Trust, LLC is ... investors the ability to fund positions using IRA’s does ... participate on a project, even if there current cash ... an additional funding source for Carson and their investors ...
    (Date:6/1/2015)... (PRWEB) June 01, 2015 The Delta ... health programs and organizations in Michigan, Ohio and Indiana ... deadline of Sept. 30, 2015 has been set. , ... in grants to organizations that specifically focus on children’s ... primarily address oral health in adults. Each grant request ...
    (Date:6/1/2015)... June 01, 2015 EBSCO Health ... today introduced DynaMed Plus™ , a cross-platform evidence-based ... professionals. It provides clinicians with the ideal blend of ... care paths. , DynaMed Plus is a significant ... includes the most frequently updated evidence-based content. DynaMed Plus ...
    (Date:6/1/2015)... KC and Monica Craichy, Founders of ... best superfood products in the world to ... , "Monica and I are excited to be ... Living Fuel Super Meals - SuperBerry®, SuperGreens and LivingProtein® ... Texas," KC Craichy said. "We have attempted to do ...
    Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3
    ... bone marrow, and known as MAPCs, have proved to ... and also in muscle tissue when treating peripheric vascular ... mouse models by two research groups, one by the ... Applied Medical Research (CIMA), also of the University of ...
    ... font of all knowledge, despite the plethora of information ... of New South Wales (UNSW) in Australia have found ... of useful materials, people pay more attention to information ... read the right material, they are stubborn to changing ...
    ... continuing operations, excluding ... guidance for full fiscal year 2008 earnings per share from, continuing operations, excluding specified ... ... N.J., Jan. 24 BD (Becton,Dickinson and Company) (NYSE: BDX ) today reported ...
    ... Allergy Friendly" Certification Now Available, WASHINGTON, ... product Certification Program administered by the,Asthma and ... with the,international research organization, Allergy Standards Limited ... & allergy friendly(TM) products., (Photo: ...
    ... formulation temporarily reserved for patients with Acute Myelogenous Leukemia ... transplantation graft failure or ... aims to restore US supplies ... WAYNE, N.J., Jan. 23 Bayer HealthCare Pharmaceuticals,Inc. announced today, ...
    ... Pa., Jan. 23 Pennsylvania,AFL-CIO President William George ... the latest decisions by,Representatives John Peterson, Joseph Pitts, ... insurance for millions of children in,families hit hardest ... see how, in the face of a severe ...
    Cached Medicine News:Health News:Adult stem cell application effective in treatment of peripheric vascular disease 2Health News:Adult stem cell application effective in treatment of peripheric vascular disease 3Health News:Why the Web tells us what we already know 2Health News:BD Announces Results For First Fiscal Quarter 2Health News:BD Announces Results For First Fiscal Quarter 3Health News:BD Announces Results For First Fiscal Quarter 4Health News:BD Announces Results For First Fiscal Quarter 5Health News:BD Announces Results For First Fiscal Quarter 6Health News:BD Announces Results For First Fiscal Quarter 7Health News:BD Announces Results For First Fiscal Quarter 8Health News:BD Announces Results For First Fiscal Quarter 9Health News:BD Announces Results For First Fiscal Quarter 10Health News:Asthma Foundation Expands Certification Program to be 'Friendly' to Millions More 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 3Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 4Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: